Galderma Group AG (SWX:GALD)

Galderma Group AG Revenue

Galderma Group AG had revenue of $3.15B USD in the half year ending June 30, 2026, with 42.06% growth. This brings the company's total for the last twelve months to $5.92B, up 26.29% year-over-year. In the year 2025, Galderma Group AG had annual revenue of $5.24B with 18.04% growth. That makes Galderma Group AG the 2,359th largest company in the world by revenue and 31st in Switzerland.

• Revenue (ttm): $5.92B
• Revenue Growth: +26.29%
• P/S Ratio: 9.50
• Revenue / Employee: $771.63K
• Employees: 7,676
• Market Cap: 45.86B CHF

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Neuromodulators 1.47B 28.1%
• Dermatological Skincare 1.45B 27.6%
• Therapeutic Dermatology 1.19B 22.6%
• Fillers & Biostimulators 1.10B 21.0%
• Other 35.00M 0.7%

By Geography

Chart

• International 2.98B 56.8%
• USA 2.23B 42.6%
• Other 34.00M 0.6%

Fiscal year ended Dec 31, 2025 See the full Galderma Group AG breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.24B	801.00M	18.04%
Dec 31, 2024	4.44B	323.00M	7.85%
Dec 31, 2023	4.12B	293.10M	7.66%
Dec 31, 2022	3.82B	378.90M	11.00%
Dec 31, 2021	3.45B	-	-

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Jul 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company. Revenue segment and geography data is provided by Fiscal.ai.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error